These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 33581054)

  • 21. Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland.
    Thiabaud A; Iten A; Balmelli C; Senn L; Troillet N; Widmer A; Flury D; Schreiber PW; Vázquez M; Damonti L; Buettcher M; Vuichard-Gysin D; Kuhm C; Cusini A; Riedel T; Nussbaumer-Ochsner Y; Gaudenz R; Heininger U; Berger C; Zucol F; Bernhard-Stirnemann S; Corti N; Zimmermann P; Uka A; Niederer-Loher A; Gardiol C; Roelens M; Keiser O
    Swiss Med Wkly; 2021 Feb; 151():w20475. PubMed ID: 33638351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoalbuminemia and clinical adverse events in children with COVID-19.
    Loffredo L; Campana A; Olivini N; Cotugno N; Palma P; Oliva A; Salvatori G; Zicari AM; Violi F
    J Med Virol; 2021 May; 93(5):2611-2613. PubMed ID: 33554335
    [No Abstract]   [Full Text] [Related]  

  • 23. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detailed analysis of underlying diseases associated with hospitalization in pediatric COVID-19.
    Chu YJ; Lee WT
    J Formos Med Assoc; 2024 Jul; 123(7):823. PubMed ID: 38631958
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Emergency Department Activity and the First COVID-19 Lockdown: A Cross-sectional Study.
    Honeyford K; Coughlan C; Nijman RG; Expert P; Burcea G; Maconochie I; Kinderlerer A; Cooke GS; Costelloe CE
    West J Emerg Med; 2021 May; 22(3):603-607. PubMed ID: 34125034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
    Dhanalakshmi K; Venkataraman A; Balasubramanian S; Madhusudan M; Amperayani S; Putilibai S; Sadasivam K; Ramachandran B; Ramanan AV
    Indian Pediatr; 2020 Nov; 57(11):1010-1014. PubMed ID: 32769230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Australia: Epidemiology Report 49 Reporting period ending 29 August 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Sep; 45():. PubMed ID: 34493181
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 Australia: Epidemiology Report 48 Reporting period ending 15 August 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Aug; 45():. PubMed ID: 34493180
    [No Abstract]   [Full Text] [Related]  

  • 30. Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020.
    Drouin O; Hepburn CM; Farrar DS; Baerg K; Chan K; Cyr C; Donner EJ; Embree JE; Farrell C; Forgie S; Giroux R; Kang KT; King M; Laffin M; Luu TM; Orkin J; Papenburg J; Pound CM; Price VE; Purewal R; Sadarangani M; Salvadori MI; Top KA; Viel-Thériault I; Kakkar F; Morris SK;
    CMAJ; 2021 Sep; 193(38):E1483-E1493. PubMed ID: 34580141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in severity, mortality, and virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2.
    Aznar-Gimeno R; Paño-Pardo JR; Esteban LM; Labata-Lezaun G; Esquillor-Rodrigo MJ; Lanas A; Abadía-Gallego D; Diez-Fuertes F; Tellería-Orriols C; Del-Hoyo-Alonso R; Serrano MT
    Sci Rep; 2021 Sep; 11(1):18844. PubMed ID: 34552127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients.
    Servidio AG; Capata G; Levantino L; Riccio G; Contorno S; Barbi E; Maschio M
    Ital J Pediatr; 2021 Jan; 47(1):12. PubMed ID: 33461569
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.
    Thompson CN; Hughes S; Ngai S; Baumgartner J; Wang JC; McGibbon E; Devinney K; Luoma E; Bertolino D; Hwang C; Kepler K; Del Castillo C; Hopkins M; Lee H; DeVito AK; Rakeman JL; ; Fine AD
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):712-716. PubMed ID: 33983915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the COVID-19 pandemic on asthma exacerbations in children: A multi-center survey using an administrative database in Japan.
    Bun S; Kishimoto K; Shin JH; Maekawa T; Takada D; Morishita T; Kunisawa S; Imanaka Y
    Allergol Int; 2021 Oct; 70(4):489-491. PubMed ID: 34281768
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 Australia: Epidemiology Report 38 Reporting period ending 28 March 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Apr; 45():. PubMed ID: 33845717
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of SARS-CoV-2 antibodies in pediatric patients: An Iranian referral hospital-based study.
    Mamishi S; Esslami GG; Mohammadi M; Abdolsalehi MR; Sadeghi RH; Mahmoudi S; Pourakbari B
    Hum Antibodies; 2021; 29(3):217-223. PubMed ID: 34151783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019.
    Beken B; Ozturk GK; Aygun FD; Aydogmus C; Akar HH
    Ann Allergy Asthma Immunol; 2021 May; 126(5):569-575. PubMed ID: 33493639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
    Hashemi SA; Safamanesh S; Ghasemzadeh-Moghaddam H; Ghafouri M; Azimian A
    J Med Virol; 2021 Feb; 93(2):1008-1012. PubMed ID: 32720703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.